Xenon Pharmaceuticals Inc. - COM (XENE)

Historical Portfolio Holders from Q4 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
73 M
Holdings value Q1 2024
$3.14 B
Value change Q1 2024
+$59.1 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
213
Number of buys Q1 2024
111
Number of sells Q1 2024
-83
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
-0.001%
CUSIP
98420N105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 73 M $3.14 B +$59.1 M $43.05 215
2023 Q4 71.8 M $3.31 B +$396 M $46.06 206
2023 Q3 61.3 M $2.09 B +$2.76 M $34.16 180
2023 Q2 61.2 M $2.36 B +$10.3 M $38.50 169
2023 Q1 61.1 M $2.18 B +$26.6 M $35.79 161
2022 Q4 60.3 M $2.38 B +$39.3 M $39.43 154
2022 Q3 56.6 M $2.04 B +$60.2 M $36.10 146
2022 Q2 57 M $1.73 B +$241 M $30.42 147
2022 Q1 49 M $1.5 B +$45 M $30.57 125
2021 Q4 47.6 M $1.49 B +$452 M $31.24 127
2021 Q3 34.1 M $521 M +$394 K $15.28 117
2021 Q2 33.3 M $620 M +$2.29 M $18.62 96
2021 Q1 32.9 M $590 M +$88.7 M $17.90 87
2020 Q4 28 M $430 M -$1.91 M $15.38 78
2020 Q3 27.9 M $309 M -$546 K $11.07 76
2020 Q2 28 M $351 M +$8.43 M $12.54 77
2020 Q1 27.7 M $314 M +$101 M $11.34 68
2019 Q4 18.7 M $245 M +$22.9 M $13.11 65
2019 Q3 16.1 M $145 M -$14.7 M $9.01 52
2019 Q2 17.6 M $173 M -$1.93 M $9.86 57
2019 Q1 17.7 M $180 M +$3.71 M $10.16 60
2018 Q4 17.5 M $110 M -$23.3 M $6.31 56
2018 Q3 17.7 M $233 M +$114 M $13.20 59
2018 Q2 9.02 M $83 M +$29.1 M $9.20 40
2018 Q1 6.34 M $31.1 M -$13.8 M $4.90 34
2017 Q4 9.16 M $25.9 M -$498 K $2.83 30
2017 Q3 9.32 M $27.5 M -$1.98 M $2.95 30
2017 Q2 9.57 M $30.1 M -$1.13 M $3.15 36
2017 Q1 10.1 M $40.3 M -$3.24 M $4.00 36
2016 Q4 10.5 M $80.8 M +$2.07 M $7.70 31
2016 Q3 9.93 M $80.2 M +$36.8 M $8.10 30
2016 Q2 5.36 M $31.7 M -$2.51 M $5.90 19
2016 Q1 5.69 M $39.8 M -$1.43 M $6.99 24
2015 Q4 5.76 M $46.3 M +$2.27 M $8.04 24
2015 Q3 5.35 M $44.2 M +$5.12 M $8.26 24
2015 Q2 4.68 M $53.9 M +$3.17 M $11.53 24
2015 Q1 4.45 M $75.2 M +$2.92 M $16.86 23
2014 Q4 4.28 M $83.1 M +$74.1 M $19.75 16